FABP1 and hepatocellular carcinoma: In vitro experiments demonstrated that FABP1 inhibition drives macrophage repolarization from immunosuppressive M2-like to immunostimulatory M1-like phenotype, concurrently reducing PD-L1 expression and impairing HCC cell proliferation [123].